Medical Marijuana Market 2018 by Worldwide Analysis, Trends, Growth, Types (Migraine, Arthritis, Cancer, Chronic Pain, and Others)-Cannabis Sativa, Cara Therapeutics, Lexaria Corp, United Cannabis Corporation

(I-TravelNewswire.Com, August 09, 2018 ) The medical marijuana market is estimated to represent a global market of USD 13.88 billion by 2017 with growth rate of 18.3%. According to the National Institute on Drug Abuse (NIDA), Marijuana (also referred as cannabis) is the dried leaves of female flowers of hemp plant which contain psychoactive properties. Delta- 9- tetrahydrocannabinol (Delta-9-THC) is the important psychoactive ingredient, the most abundant cannabinoid presents in marijuana. The movement to accept cannabis as a medicine is propel by multiple factors, including inadequate relief of current available treatment approaches for number of chronic disease conditions such as Crohn's disease, multiple Sclerosis, cancer, Alzheimer's disease, and chronic pain. Such conditions are frequently cited by the proponents of marijuana i.e. cannabis for medical use. The market for medical marijuana is primarily driven by the growing application of marijuana in mentioned medical conditions.

Furthermore, large number of companies are increasingly investing in this market to capture significant revenue share. For example, Australia based MMJ PhytoTech Limited is considered to be the pioneer in the development of medical cannabis for international market, under regulated medical cannabis laws. The company is the first medical grade cannabis (MGC) company to list on the ASX. PhytoTech is primarily focused on the research and development activities on MGC therapeutics to be used in various medical applications. The company is aimed to become a leader in commercialization of cannabinoids based therapeutic products. Such initiatives would in turn help this market to establish healthy platform, hence drives the market growth. However, low penetration of marijuana for medical application in some developed as well as developing countries hamper the market growth.

Complete report is available@ www.reportsweb.com/inquiry&RW00011327825/sample

The market is categorized as Migraine, Arthritis, Cancer, Chronic Pain, and Others. Chronic pain segment achieved largest share of the total medical marijuana market, captured 35.26% share of the market. The use of pain medication is rapidly increasing, imposing a major burden on the healthcare system. The use of medical marijuana is reported to significantly alleviate pain symptoms. Its application in cancer and arthritis is also considered to be growing in near future due to advancements and increasing awareness among patient population.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPES
Migraine
Arthritis
Cancer
Chronic Pain
Others

MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World

MARKET, BY COUNTRY
Further Breakdown of The North America Market
U.S.
Canada

Further Breakdown of The Europe Market
Germany
France
Finland
Romania
Italy
Rest of Europe

Further Breakdown of The APAC Market
India
China

Rest of APAC
Further Breakdown of The Rest of the World Market
Middle East and Africa
Latin America

Inquire before Buying@ www.reportsweb.com/inquiry&RW00011327825/buying

Competitive Landscape:
Cannabis Sativa
Cara Therapeutics
Lexaria Corp
United Cannabis Corporation
CannaGrow Holdings Inc.
International Consolidated Companies, Inc.

ReportsWeb.com

Rajat Sahni

+1-646-491-9876

sales@reportsweb.com

Source: EmailWire.Com